Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David L Paterson

Showing results (51-60 of 574) with videos related to

Pageof 58
Sort By:
The Lancet. Infectious Diseases|November 26, 2015
Colistin resistance: a major breach in our last line of defenceDavid L Paterson, Patrick N A Harris
Infectious Disease Clinics of North America|January 14, 2026
How to Treat Carbapenem-Resistant Acinetobacter baumannii Infections: Current Knowledge and Personal ViewpointsAntonio Cascio, Luca Pipitò, David L Paterson
Clinics in Laboratory Medicine|June 5, 2004
Antibiotic-resistant infections in the critically ill adultFernanda Silveira, Shigeki Fujitani, David L Paterson
Perspectives in Clinical Research|August 1, 2015
Reporting of pre-enrolment screening with randomized clinical trials: A small item that could impact a big differenceTiffany M Harris-Brown, David L Paterson
Frontiers in Medicine|August 19, 2021
Editorial: Spotlight on the Relationship Between Sepsis and Infection: From Mechanisms to TherapyAlessandro Russo, David L Paterson, Matteo Bassetti
Antimicrobial Agents and Chemotherapy|November 17, 2010
Systematic review and meta-analysis of the significance of heterogeneous vancomycin-intermediate Staphylococcus aureus isolatesSebastiaan J van Hal, David L Paterson
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 1, 2015
Editorial commentary: the new Acinetobacter equation: hypervirulence plus antibiotic resistance equals big troubleDavid L Paterson, Patrick N A Harris
Journal of Acquired Immune Deficiency Syndromes (1999)|February 4, 2003
Measurement of adherence to antiretroviral medicationsDavid L Paterson, Brian Potoski, Blair Capitano
Current Opinion in Infectious Diseases|February 19, 2020
New treatment options for multiresistant gram negativesDavid L Paterson, Burcu Isler, Adam Stewart
Current Pharmaceutical Biotechnology|December 23, 2011
Reducing the development of antibiotic resistance in critical care unitsMarjolein P D Deege, David L Paterson
Pageof 58

Showing results (51-60 of 574) with videos related to

Sort By:
Pageof 58
The Lancet. Infectious Diseases|November 26, 2015
Colistin resistance: a major breach in our last line of defenceDavid L Paterson, Patrick N A Harris
Infectious Disease Clinics of North America|January 14, 2026
How to Treat Carbapenem-Resistant Acinetobacter baumannii Infections: Current Knowledge and Personal ViewpointsAntonio Cascio, Luca Pipitò, David L Paterson
Clinics in Laboratory Medicine|June 5, 2004
Antibiotic-resistant infections in the critically ill adultFernanda Silveira, Shigeki Fujitani, David L Paterson
Perspectives in Clinical Research|August 1, 2015
Reporting of pre-enrolment screening with randomized clinical trials: A small item that could impact a big differenceTiffany M Harris-Brown, David L Paterson
Frontiers in Medicine|August 19, 2021
Editorial: Spotlight on the Relationship Between Sepsis and Infection: From Mechanisms to TherapyAlessandro Russo, David L Paterson, Matteo Bassetti
Antimicrobial Agents and Chemotherapy|November 17, 2010
Systematic review and meta-analysis of the significance of heterogeneous vancomycin-intermediate Staphylococcus aureus isolatesSebastiaan J van Hal, David L Paterson
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 1, 2015
Editorial commentary: the new Acinetobacter equation: hypervirulence plus antibiotic resistance equals big troubleDavid L Paterson, Patrick N A Harris
Journal of Acquired Immune Deficiency Syndromes (1999)|February 4, 2003
Measurement of adherence to antiretroviral medicationsDavid L Paterson, Brian Potoski, Blair Capitano
Current Opinion in Infectious Diseases|February 19, 2020
New treatment options for multiresistant gram negativesDavid L Paterson, Burcu Isler, Adam Stewart
Current Pharmaceutical Biotechnology|December 23, 2011
Reducing the development of antibiotic resistance in critical care unitsMarjolein P D Deege, David L Paterson
Pageof 58